Development Technologies Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Daniel Kesonen
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 19.2yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | no data |
Recent management updates
No updates
Recent updates
No updates
CEO
Daniel Kesonen
19.2yrs
Tenure
Mr. Daniel P. Kesonen serves as the Chairman at Development Technologies Corp. (formerly known as Pegasus Pharmaceuticals Inc.) and its Chief Executive Officer and President since January 2005. Mr. Kesonen...